Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
July 10, 2017
Cobra Biologics

International Trade Award Presented to Cobra Biologics

Recognising companies who excel in the exportation of a product or service to an international market.

International Trade Award Presented to Cobra Biologics

Recognising companies who excel in the exportation of a product or service to an international market.

-
Cobra Biologics
-
July 10, 2017

Cobra Biologics has been recognised with the International Trade Award at the Staffordshire Business Awards 2017.

Presented last night at an awards ceremony at the Staffordshire County Showground, the awards are organised by the Staffordshire Chambers of Commerce to showcase the achievements, success stories and outstanding performance of Staffordshire’s best businesses.

From hundreds of entries, a Steering Committee selected  three finalists from each of the 13 award categories; Cobra was shortlisted for both the International Trade Award, sponsored by the Department for International Trade (DIT, formerly UKTI), and Business of the Year, sponsored by HSBC.

The International Trade Award recognises companies who excel in the exportation of a product or service to an international market including identification of the opportunity, product or service development, international partnerships, overseas sales and marketing and the overall benefit this brings to Staffordshire. The team at Cobra is delighted to have won such a prestigious accolade.

Peter Coleman, CEO Cobra Biologics, commented: “I am incredibly proud of what Cobra has achieved; exporting 98% of our manufacturing services and helping to develop and manufacture drugs for the benefit of patients around the world.”

Pictured L-R: Robert Lawley (Head of the DIT), Steve Garland (Keele Site Manager, Cobra Biologics), Peter Coleman (CEO Cobra Biologics), Sarah Davies (GMP Production Manager, Cobra Biologics), Nick Smith (Head of Production and Technical Support Services, Cobra Biologics)
Last updated:
July 10, 2017

Cobra Biologics

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. Cobra has three GMP approved facilities in Sweden and the UK, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

Cobra Biologics has been recognised with the International Trade Award at the Staffordshire Business Awards 2017.

Presented last night at an awards ceremony at the Staffordshire County Showground, the awards are organised by the Staffordshire Chambers of Commerce to showcase the achievements, success stories and outstanding performance of Staffordshire’s best businesses.

From hundreds of entries, a Steering Committee selected  three finalists from each of the 13 award categories; Cobra was shortlisted for both the International Trade Award, sponsored by the Department for International Trade (DIT, formerly UKTI), and Business of the Year, sponsored by HSBC.

The International Trade Award recognises companies who excel in the exportation of a product or service to an international market including identification of the opportunity, product or service development, international partnerships, overseas sales and marketing and the overall benefit this brings to Staffordshire. The team at Cobra is delighted to have won such a prestigious accolade.

Peter Coleman, CEO Cobra Biologics, commented: “I am incredibly proud of what Cobra has achieved; exporting 98% of our manufacturing services and helping to develop and manufacture drugs for the benefit of patients around the world.”

Pictured L-R: Robert Lawley (Head of the DIT), Steve Garland (Keele Site Manager, Cobra Biologics), Peter Coleman (CEO Cobra Biologics), Sarah Davies (GMP Production Manager, Cobra Biologics), Nick Smith (Head of Production and Technical Support Services, Cobra Biologics)
Last updated:
July 10, 2017

Cobra Biologics

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. Cobra has three GMP approved facilities in Sweden and the UK, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail